Coverage of our peer-reviewed research in the healthcare and mainstream press.
A Forbes contributor article called “Precision Cancer Trials Are Booming Despite Skeptics Who Doubt Their Value” referenced a newsroom article by The American Journal of Managed Care (AJMC)® covering the American Society of Hematology’s Annual Meeting. Written by Surabhi Dangi-Garimella, PhD, the AJMC® coverage discussed 2 innovative clinical trials developed by “Beat Acute Myeloid Leukemia and the National Cancer Institute-Molecular Analysis for Therapy Choice, which incorporate genomic profiling to assign patients to different treatment arms.”
A study in AJMC®’s Health Information Technology (IT) special issue was covered by Health IT Analytics. The AJMC® research, “Building Health IT Capacity to Improve HIV Infection Health Outcomes,” explained how the Massachusetts Virtual Epidemiologic Network project integrates patient data from across the HIV care continuum.
Researchers studied the impact of virtual health coach technology and published their findings in a recent article from The American Journal of Accountable Care® article titled “Can a Virtual Coach Activate Patients? A Proof of Concept Study.” Those findings were summarized in a Patient Engagement HIT, which discussed how the virtual coach could help boost patient engagement and facilitate patient-provider discussions.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More